Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench

Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers’ breath away

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?

Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma

Are 50 years enough to prove the brilliant Dilman’s idea?

GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells

Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition

Redefining and expanding the sphere of influence of BRCA in breast and colorectal cancers and beyond

Suppressive GLI2 fragment enhances liver metastasis in colorectal cancer

Seventh BHD international symposium: recent scientific and clinical advancement

Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein

Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications

Correction: The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers

Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer

Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer

Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice

A liquid fraction of extracellular matrix inhibits glioma cell viability in vitro and in vivo

Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations

Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge

Correction: Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14

Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity

Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification

Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients

Retraction: Transcriptome analysis reveals a role for the endothelial ANP-GC-A signaling in interfering with pre-metastatic niche formation by solid cancers

Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates

Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Role of the prorenin receptor in endometrial cancer cell growth

Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2

Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis

Correction: MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment

Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells

Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study

Correction: LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells

CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling

Correction: Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells

Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes

Targeting lipid metabolism in the treatment of ovarian cancer

Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma

IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells

Correction: Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program

Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF

Role of germline variants in the metastasis of breast carcinomas

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II

Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9

Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma

An ABC transporter as a potential target against SHH-Medulloblastoma: From Benchtop to Bedside

Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model

Retraction: MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK

Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation

Correction: Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer

Genomic alterations predictive of poor clinical outcomes in pan-cancer

Correction: Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained

Correction: Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved

HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs

FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers

Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer

Correction: Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models

Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma

Nectin-4 is widely expressed in head and neck squamous cell carcinoma

Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

Retraction: SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

Treasures from trash in cancer research

Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer

Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention

Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more

Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis

Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors

The future of bioorthogonal-chemistry for targeting of exosomes in precision medicine

Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD)

Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity

The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies

Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR

Impact of Covid-19 on the management of patients with metastatic melanoma